Drug Shortage Report for JAMP LAMIVUDINE / ZIDOVUDINE
| Report ID | 207304 |
| Drug Identification Number | 02502801 |
| Brand name | JAMP LAMIVUDINE / ZIDOVUDINE |
| Common or Proper name | Lamivudine and Zidovudine Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | LAMIVUDINE ZIDOVUDINE |
| Strength(s) | 150MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-10-16 |
| Estimated end date | 2024-09-30 |
| Actual end date | 2024-05-09 |
| Shortage status | Resolved |
| Updated date | 2024-05-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2024-05-10 | English | Compare |
| v11 | 2024-05-09 | French | Compare |
| v10 | 2024-05-09 | English | Compare |
| v9 | 2024-03-19 | French | Compare |
| v8 | 2024-03-19 | English | Compare |
| v7 | 2024-02-06 | French | Compare |
| v6 | 2024-02-06 | English | Compare |
| v5 | 2023-11-15 | French | Compare |
| v4 | 2023-11-15 | English | Compare |
| v3 | 2023-10-18 | French | Compare |
| v2 | 2023-10-18 | English | Compare |
| v1 | 2023-10-18 | English | Compare |
Showing 1 to 12 of 12